title: Treatment strategy for metastatic brain tumors from renal cell carcinoma: selection of gamma knife surgery or craniotomy for control of growth and peritumoral edema.
abstract: We retrospectively studied the efficacy of gamma knife surgery (GKS) for metastatic brain tumors from renal cell carcinoma (RCC). To evaluate the efficacy of GKS for control of peritumoral edema, we retrospectively studied 280 consecutive metastatic brain tumors (100 from lung cancers, 100 from breast cancers, and 80 from RCC) associated with peritumoral edema. In addition, this study included 11 patients with metastatic brain tumors from RCC who underwent direct surgery. The tumor growth control rate of GKS was 84.3%. The extent of edema of RCC metastases was significantly larger than those from lung and breast cancer. Primary site (renal or not renal) and delivered marginal dose (25 Gy or more) were significantly correlated with control of peritumoral edema. All tumors treated by direct surgery were more than 2 cm in maximum diameter. Peritumoral edema at surgery was extensive but disappeared within 1-3 months, and neurological symptoms also improved in many cases. Total removal of brain metastases from RCC was easy with little bleeding in most cases. Our results suggest that GKS is effective for growth control of metastatic brain tumors from RCC. Higher marginal dose such as 25 Gy or more is desirable to obtain peritumoral edema control, so GKS is not suitable for control of symptomatic peritumoral edema associated with relatively large tumors. Tumor removal of RCC metastases is relatively easy and rapidly reduces peritumoral edema. Treatment strategy for metastatic brain tumors from RCC depends on tumor size, number of tumors, and presence of symptomatic peritumoral edema.
authors.affiliation: Department of Neurosurgery, Yokohama Rosai Hospital, 3211 Kozukue-cho, Kouhoku-ku, Yokohama, Kanagawa, 222-0036, Japan. shuto@yokohamah.rofuku.go.jp
authors.forename: Takashi
authors.initials: T
authors.lastname: Shuto
authors.forename: Shigeo
authors.initials: S
authors.lastname: Matsunaga
authors.forename: Jun
authors.initials: J
authors.lastname: Suenaga
authors.forename: Shigeo
authors.initials: S
authors.lastname: Inomori
authors.forename: Hideyo
authors.initials: H
authors.lastname: Fujino
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000556:secondary* / Q000601:surgery*; D002292:Carcinoma, Renal Cell / Q000473:pathology*; D003399:Craniotomy / Q000379:methods*; D004487:Edema / Q000209:etiology / Q000601:surgery; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D016634:Radiosurgery / Q000379:methods*; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
references.citation: Int J Radiat Oncol Biol Phys. 1992;24(4):619-25
references.pmid: 1429083
references.citation: N Engl J Med. 1990 Feb 22;322(8):494-500
references.pmid: 2405271
references.citation: Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):253-8
references.pmid: 14697446
references.citation: Int J Radiat Oncol Biol Phys. 1985 Nov;11(11):2007-9
references.pmid: 2414257
references.citation: Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1389-93
references.pmid: 11121638
references.citation: Minim Invasive Neurosurg. 2004 Aug;47(4):203-8
references.pmid: 15346315
references.citation: Anticancer Res. 2007 Nov-Dec;27(6C):4255-7
references.pmid: 18214028
references.citation: J Neurosurg. 2000 Dec;93 Suppl 3:32-6
references.pmid: 11143259
references.citation: Cancer. 1983 Feb 15;51(4):614-7
references.pmid: 6185207
references.citation: Cancer. 1998 Jul 15;83(2):344-53
references.pmid: 9669818
references.citation: Cancer. 1981 Sep 15;48(6):1487-91
references.pmid: 7272969
references.citation: Cancer J. 2000 Nov-Dec;6(6):372-6
references.pmid: 11131486
references.citation: Acta Neurochir (Wien). 2003 Sep;145(9):755-60
references.pmid: 14505101
references.citation: Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1279-83
references.pmid: 12128130
references.citation: Int J Urol. 2002 Nov;9(11):618-25; discussion 626; author reply 627
references.pmid: 12534903
references.citation: J Neurosurg. 2002 Dec;97(5 Suppl):489-93
references.pmid: 12507083
references.citation: J Neurosurg. 1993 Aug;79(2):210-6
references.pmid: 8331402
references.citation: J Neurosurg. 2002 Oct;97(4):785-93
references.pmid: 12405364
references.citation: J Neurosurg. 2006 Oct;105(4):555-60
references.pmid: 17044558
references.citation: J Neurosurg. 2003 Feb;98(2):342-9
references.pmid: 12593621
references.citation: J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1061-5
references.pmid: 18245140
references.citation: J Neurooncol. 2009 Jan;91(1):47-50
references.pmid: 18712279
references.citation: Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1007-12
references.pmid: 10863072
references.citation: Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):797-802
references.pmid: 8138431
references.citation: Acta Neurochir (Wien). 1998;140(6):549-55
references.pmid: 9755321
references.citation: Stereotact Funct Neurosurg. 1998 Oct;70 Suppl 1:41-9
references.pmid: 9782234
references.citation: Urol Oncol. 2004 Jan-Feb;22(1):25-31
references.pmid: 14969800
references.citation: Acta Neurochir (Wien). 2004 Sep;146(9):989-93; discussion 993
references.pmid: 15340810
references.citation: Cancer. 1986 Aug 1;58(3):641-9
references.pmid: 3731022
references.citation: Neurosurgery. 2002 Sep;51(3):656-65; discussion 665-7
references.pmid: 12188943
references.citation: Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1543-8
references.pmid: 19135317